Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Guo-Fu Li

24PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

Sort by Publication Date:
|Oct 28, 2025
Response to Comment on: "Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E-Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations".

Shi-Jie Zhang, Guo Yu, Guo-Fu Li

|Jul 02, 2025
Methodologic Considerations in Assessing Invasive Disease-Free Survival as a Surrogate End Point for Overall Survival in Trials for Early Breast Cancer.

Xiao-Jing Li, Guo Yu, Guo-Fu Li

|Feb 17, 2025
Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E-Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations.

Na Zhang, Yu-Wei Qiao, Dan Su

|Dec 03, 2024
Non-Linear Trends in the Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) From 1990 to 2021.

Na Zhang, Jie Guo, Guo Yu

|Nov 18, 2024
Overall Mortality and Cardiovascular Mortality Associated With MAFLD+/NAFLD- Versus MAFLD-/NAFLD+: A Secondary Analysis.

Guiying Gao, Ai-Jia Guan, Guo-Fu Li

|Jul 08, 2024
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence.

Yang Yu, Guo-Fu Li, Jian Li

Pageof 4

Frequent Collaborators

8 joint publications

Guo Yu

2 joint publications

Ai-Jia Guan

1 joint publications

Zheng Jiao

1 joint publications

Junyi Wu

1 joint publications

Chen Wang

Frequent Collaborators

8 joint publications

Guo Yu

2 joint publications

Ai-Jia Guan

1 joint publications

Zheng Jiao

1 joint publications

Junyi Wu

Top Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on : Jan 25, 2015

13.9K
Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

8.8K
See more related videos

Top Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on : Jan 25, 2015

13.9K
Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

8.8K
See more related videos